Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...

Abbott has won an innovation award for Lingo, its first consumer biowearable over-the-counter device to empower people in improving overall health and wellness.

Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

system to integrate with the newly available FreeStyle Libre 2 Plus sensor, Abbott’s latest CGM technology. Abbott is currently working with other leading insulin pump manufacturers to integrate ...

Insulet is also planning to expand its international offerings with additional sensor of choice by further launching Omnipod 5 integrated with FreeStyle Libre 2 Plus and ... at $3.92 in the ...

Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

Competitor Abbott currently has 15-day sensors with its Freestyle Libre 2 Plus and Freestyle Libre 3 Plus devices, which the FDA cleared in 2023. Sayer said having a 15-day sensor is important because ...

This step up from the standard Stylo 3 has a better screen, more memory, and NFC. Other features of this large Android phone are similar, including a large 5.7-inch screen with stylus, and a ...

ON FEBRUARY 7th the inaugural tournament of the Freestyle Chess Grand Slam Tour will begin on Germany’s Baltic Sea coast. My anticipation is immense. At the Weissenhaus Resort, the world’s top ...